Horizon Therapeutics PLC (HZNP)
57.23
-0.77 -1.33%
NASDAQ
Jul 10, 20:00
Delayed 2m
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 1.376B |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 2.83 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 592.29M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 72.63% |
| Profit Margin (Quarterly) | -3.82% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 0.00% |
| Price and Valuation | |
| Market Cap | 11.21B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | 8.785 |
| PE Ratio | 20.22 |
| Price to Book Value | 5.125 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | 0.6207 |
| Free Cash Flow (Quarterly) | -181.60M |
| Return on Equity | Upgrade |
View All HZNP News
News
-
WireHeadlineTime (ET)
-
MT Newswires07/09 09:41
-
Business Wire07/09 08:30
-
SA Breaking News07/09 08:22
-
PR Newswire07/09 08:00
-
Yahoo07/08 10:00
-
Yahoo07/07 16:49
-
Yahoo07/07 10:00
-
SA Breaking News07/01 19:09
-
Business Wire07/01 09:00
-
Yahoo06/23 11:38
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 08/07/2020 08:00 EDT | Misc | Horizon Therapeutics PLC Second Quarter Earnings Conference Call in 2020 |
| 08/07/2020 | Earnings | Horizon Therapeutics PLC Second Quarter Earnings in 2020 Release |
| 05/06/2020 08:00 EDT | Misc | Horizon Therapeutics PLC First Quarter Earnings Conference Call for 2020 |
| 05/06/2020 | Earnings | Horizon Therapeutics PLC First Quarter Earnings Result for 2020 |
| 04/30/2020 | Misc | Horizon Therapeutics PLC Annual General Meeting for 2019 |
| 02/26/2020 08:00 EST | Misc | Horizon Therapeutics PLC Fourth Quarter Earnings Conference Call for 2019 |
| 02/26/2020 | Earnings | Horizon Therapeutics PLC Fourth Quarter Earnings for 2019 Release |
| 11/06/2019 08:00 EST | Misc | Horizon Therapeutics PLC Third Quarter Earnings Conference Call for 2019 |
| 11/06/2019 | Earnings | Horizon Pharma PLC Third Quarter Earnings in 2019 Release |
| 08/07/2019 08:00 EDT | Misc | Horizon Pharma PLC Second Quarter Earnings Conference Call in 2019 |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- URL: https://www.horizonpharma.com
- Investor Relations URL: http://ir.horizon-pharma.com/
- HQ State/Province: N/A
- Sector: Healthcare
- Industry: Drug Manufacturers - General
- Equity Style: Mid Cap/Growth
- Next Earnings Release: Aug. 07, 2020
- Last Earnings Release: May. 06, 2020
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Horizon Therapeutics PLC is a specialty and generic drug manufacturing company. The company is focused on researching, developing and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases. The company has two reportable segments: orphan and rheumatology segment and the inflammation segment. It markets medicines in the areas of orphan diseases, rheumatology and inflammation division. The majority of revenue is generated in the United States.
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 57.23 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Top Fund Holders
| Symbol | Name | Weighting |
|---|---|---|
| XPH | SPDR® S&P Pharmaceuticals ETF | 5.36% |
| IHE | iShares US Pharmaceuticals ETF | 5.04% |
| JCNIX | Janus Henderson Contrarian S | 3.09% |
| WSMRX | William Blair Small-Mid Cap Growth R6 | 3.07% |
| PTH | Invesco DWA Healthcare Momentum ETF | 2.88% |
| FXH | First Trust Health Care AlphaDEX® ETF | 1.99% |
| CSMSX | Carillon Scout Mid Cap R-5 | 1.97% |
| JGLYX | JPMorgan Small Cap Growth R4 | 1.61% |
| HSRSX | Carillon Eagle Small Cap Growth R5 | 1.34% |
| IBB | iShares Nasdaq Biotechnology ETF | 1.15% |
| DFSTX | DFA US Small Cap I | 0.53% |
| SCHA | Schwab US Small-Cap ETF™ | 0.44% |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- HZNP Tweets Stocktwits
Advertisement
